Abstract

Diabetes, a widespread metabolic disorder, is a major public health concern. To address the ongoing need for effective diagnosis, a novel approach has been developed that allows the rapid, low-cost, and ultra-sensitive detection of disease-specific biomarkers in various body fluids using a single platform. Notably, this method focuses on biomarkers found in human sweat—glucose, L-Tryptophan, uric acid, and acetone—that are indicative of diabetes. The new strategy involves a nanozyme-based colorimetric sensor array made from a Ce/Fe fumarate biological metal–organic framework (Ce/Fe-Fum Bio-MOF) doped with Cu and Ni, and further enhanced with Ag nanoparticles. This nanozyme displays multiple enzyme-like activities, which result in distinct color changes when tested with specific chromogenic substrates. When these color changes are reduced by the introduction of biomarkers, the results can be easily captured using a smartphone. This method offers a wide linear detection range (20–1000 µM) and low detection limits for each biomarker, showing strong selectivity, reproducibility, and practical performance in detecting biomarkers in human sweat samples. The integration of smartphone signaling with this sensor array creates potential for a portable, handheld device for point-of-care applications, and could also be adapted for other sensing and biosensing needs. This colorimetric assay marks a significant advancement in the detection of diabetes biomarkers and the development of point-of-care diagnostic systems.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.